PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$20.03M
Total Shares
17.88M
Net Share Change
-56.4K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Patient Capital Management
$20.03M17.88M shares
TRIM-56.4K(-0.3%)